October 2, 2024Journal of Clinical Oncology

Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members

View Full Paper

Ask AI

Bookmark

Total episode spending decreased significantly for nontargeted patients under the oncology care model, while hospital and emergency visits remained unchanged.
Episode spending dropped by an adjusted $6,287 across practices, driven largely by reductions in outpatient care and infused systemic anticancer therapy.
Observational study using administrative claims evaluated 125 oncology care model practices, highlighting spillover spending reductions in nontargeted cohorts.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational study finds reduced episode spending in commercially insured and Medicare Advantage cancer patients, highlighting broader spillover savings from the Oncology Care Model.

Cite This Study

Mullangi et al. (2024) studied this question.

synapsesocial.com/papers/68e55ef6e2b3180350efc5c0 https://doi.org/10.1200/jco.24.00502

View Full Paper

Ask AI

Bookmark

Implication

Observational study finds reduced episode spending in commercially insured and Medicare Advantage cancer patients, highlighting broader spillover savings from the Oncology Care Model.

Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members

Key Points

Discussion

Implication

Cite This Study

Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider